Developmental pharmacology: Past, present and future

Pediatrics International

Volumn 38, Issue 6, 1996, Pages 555-561

  Blumer, Jeffrey L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Developmental pharmacology; Pediatric therapy; Pharmacodynamics; Pharmacokinetics; Teratology

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; DIAZEPAM; DIGOXIN; HALOTHANE; ISONIAZID; LIDOCAINE; MORPHINE; NAFCILLIN; PARACETAMOL; PHENOBARBITAL; PHENOTHIAZINE; PHENYTOIN; PROPRANOLOL DERIVATIVE; THEOPHYLLINE; VALPROIC ACID; VERAPAMIL;

ARTICLE; CARDIOPULMONARY INSUFFICIENCY; COGNITIVE DEFECT; DRUG ELIMINATION; DRUG PROTEIN BINDING; DRUG RESEARCH; DRUG THERAPY; DYSTONIA; HUMAN; HYPERACTIVITY; LIVER TOXICITY; PEDIATRICS; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; TERATOGENESIS; TERATOLOGY; TREATMENT PLANNING;

ABSORPTION; HUMANS; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PHARMACOLOGY;

EID: 0029857991     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1996.tb03708.x     Document Type: Article

References (30)

1. Yaffe SJ, Aranda JV. Introduction and historical prospectives. In: Yaffe SJ, Aranda JV (eds). Pediatric Pharmacology, 2nd edn. WB Saunders, Philadelphia. 1992; 3–9.
2. Lenz W. Kindliche missbildungen nach medikament wahrend der draviditate? Dsch. Med. Wochenschr. 1961; 86: 2555–6.
3. McBride WG. Thalidomide and congenital abnormalities. Lancet 1961; 2: 1358.
4. Shirkey H. Editorial comments: Therapeutic orphans. J. Pediatr. 1968; 72: 119–20.
5. Wilson JT. Pragmatic assessment of medicines available for young children and pregnant or breast feeding women. In: Moreselli P., Garattini S., Sereni F. (eds). Basic and Therapeutic Aspects of Perinatal Pharmacology. Raven Press, New York. 1975: 76–112.
6. Boreus LO. Pharmacokinetics in children. In: Boreus LO (ed.) Principles of Pediatric Pharmacology. Churchill Livingston, Edinburgh. 1982; 135–75.
7. Green TP, Mirkin BL. Clinical pharmacokinetics pediatric considerations. In: Benet L., Massoud N., Gambertoglio JG (eds). Pharmacokinetics Basis for Drug Treatment. Raven Press, New York. 1984; 269–82.
8. Milsap RL, Szefler SJ. Special pharmacokinetic considerations in children. In: Evans WE et al. (eds). Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring, Applied Therapeutics, 2nd edn. Spokane 1986; 294–330.
9. MacLeod SM. Clinical pharmacokinetics: A pediatric overview. In: MacLeod SM, Raddle IC (eds). Textbook of Pediatric Clinical Pharmacology. PSG Publishing, Littleton. 1985; 106–11.
10. Besunder JB, Reed MD, Blumer JL. Principles of drug disposition in the neonate: A critical evaluation of the pharmacokinetics-pharmacodynamic interface (Parts I & II). Clin. Pharmacokinet. 1988; 14: 189–216 & 261–86.
11. Keams GL, Reed MD. Clinical pharmacokinetics in infants and children: A reappraisal. Clin. Pharmacokinet. 1989; 17 (Suppl. 1): 29–67.
12. Roberts RJ. Special considerations in drug therapy in infants. In: Drug Therapy in Infants: Pharmacologic Principles and Clinical Experience. WB Saunders, Philadelphia. 1984; 25–35.
13. Rose FW. Epidemiology of drugs in pregnancy. In: Yaffe SJ, Aranda JV (eds). Pediatric Pharmacology, 2nd edn. WB Saunders, Philadelphia. 1992; 97–106.
14. Fraser FC. Teratology. In: Yaffe SJ, Aranda JV (eds). Pediatric Pharmacology, 2nd edn. WB Saunders, Philadelphia. 1992; 107–10.
15. Shapiro BH. Delayed teratogenic expression. In: Yaffe SJ, Aranda JV (eds). Pediatric Pharmacology, 2nd edn. WB Saunders, Philadelphia. 1992; 122–7.
16. Hales BF. Teratology: Biochemical mechanisms. In: Yaffe SJ, Aranda JV (eds). Pediatric Pharmacology, 2nd edn. WB Saunders, Philadelphia. 1992; 122–7.
17. Farrar HF, Blumer JL. Fetal effects of maternal drug exposure. Annu. Rev. Pharmacol. Toxicol. 1991; 31: 525–47.
18. Reed MD, Blumer JL. Fetal therapy. In: Fanaroff AA, Martin RJ (eds). Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant, 6th edn. Mobsy, St. Louis, (in press).
19. Blumer JL, Reed MD. Principles of neonatal pharmacology. In: Yaffe SJ, Aranda JV (eds). Pediatric Pharmacology, 2nd edn. WB Saunders, Philadelphia. 1992; 164–77.
20. Kaffman RE. Drug therapeutics in the infant and child. In: Yaffe SJ, Aranda JV (eds). Pediatric Pharmacology, 2nd edn. WB Saunders, Philadelphia. 1992; 212–19.
21. Hein K. Drug therapeutics in the adolescent. In: Yaffe SJ, Aranda JV (eds). Pediatric Pharmacology, 2nd edn. WB Saunders, Philadelphia. 1992; 220–36.
22. Radde IC. Mechanisms of drug absorption and their development. In: MacLeod SM, Radde IC (eds). Textbook of Pediatric Clinical Pharmacology. PSG Publishing, Littlehorn. 1985; 17–43.
23. Fries-Hansen B. Water distribution in the fetus and the newborn infant. Acta Paediatr. Scand. 1983; 305 (Suppl.): 7–11.
24. Gonzalez FJ, Idle JR. Pharmacogenetic phenotyping and genotyping. Present status and future potential. Clin. Pharmacokinet. 1994; 26: 59–70.
25. May DG. Genetic differences in drug disposition. J. Clin. Pharmacol. 1994; 34: 881–97.
26. Arant BS Jr. Developmental patterns of renal functional maturation compared in the human neonate. J. Pediatr. 1978; 92: 705–12.
27. Marx CM, Pope J., Blumer JL. Developmental toxicology. In: Haddad LM, Winchester JF (eds). Clinical Management of Poisoning and Drug Overdose, 2nd edn. WB Saunders, Philadelphia. 1990; 388–435.
28. Lammer EJ, Chen DT, Hoar RM et al. Retenoic acid embryopathy. N. Engl. J. Med. 1985; 313: 837–41.
29. Federal Register Part II, Department of Health and Human Services Food and Drug Administration, 21 CFR Part 201. Specific Requirements on contract and format of labeling for human prescription drugs: Revision of ‘Pediatric Use’ subsection in the labeling. Final Rule, Tuesday, December 13, 1994.
30. NIH Consensus Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes. Volume 12, Number 2, 28 February, 2 March 1994.